Possible COVID-19 vaccine waiting on approval from Health Canada

Must Read

Dan Davies officially kicks-off reelection campaign

FORT ST. JOHN, B.C. - Incumbent Peace River North MLA Dan Davies officially kicked-off his re-election campaign on Friday...

Dawson Creek RCMP detachment experiencing phone system issues

DAWSON CREEK, B.C. - Dawson Creek RCMP are reporting an issue with their phone system at the detachment. According to...

Inland opens new Fort St. John Facility at existing location

FORT ST. JOHN, B.C. - Inland is announcing the completion of their new Fort St. John facility. According to Inland, ...

KIRKLAND, QC & MAINZ, GERMANY – Pfizer Canada and BioNTech have announced Wednesday, August 5, 2020, that they have reached an agreement with the Government of Canada to supply their BNT162 mRNA-based vaccine that could be used against COVID-19. This will be subject to the clinical success of the vaccine and approval from Health Canada.

The financials were not released, but the terms are based on the timing of delivery and volume of doses. By the end of 2020, there should be around 100 million doses manufactured and approximately 1.3 billion doses by the end of 2021.

The BNT162 program is based upon BioNTech’s mRNA technology and is supported by Pfizer’s global vaccine development and its manufacturing capabilities.

- Advertisement -

The vaccine development program will be looking at at least four experimental vaccine candidates, with each of them representing a unique combination of messenger RNA (mRNA) format and a target antigen.

These vaccine candidates are undergoing clinical studies and aren’t approved for distribution anywhere in the world yet. Both collaborators are committed to working to develop these vaccines with pre-clinical and clinical data at the forefront of all their decision-making.

If clinical trials are successful, Pfizer and BioNtech could be on track to seek a review as early as October 2020.

- Advertisement -

Community Interviews with Moose FM


Subscribe to our newsletter

Get the latest news delivered to your mailbox every morning.

More Articles Like This